![Elisa Scarselli](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Actieve functies van Elisa Scarselli
Bedrijven | Functie | Begin | Einde |
---|---|---|---|
Nouscom AG
![]() Nouscom AG Pharmaceuticals: MajorHealth Technology Nouscom AG engages in the development of genetic neoantigen vaccines and oncolytic viruses for prevention and treatment of cancer. Its product pipeline include Nous-209, Nous-PEV, and Nous-THV-001. The company was founded by Alfredo Nicosia, Antonella Folgori, Riccardo Cortese, Stefano Colloca, Cinzia Traboni, Elisa Scarselli, and Gabriella Campadelli in 2007 and is headquartered in Basel, Switzerland. | Hoofd Techniek/Wetenschap/O&O | 01-01-2007 | - |
Oprichter | 01-01-2007 | - | |
Nouscom Srl | Hoofd Techniek/Wetenschap/O&O | 01-01-2015 | - |
Oprichter | 01-01-2015 | - |
Loopbaan van Elisa Scarselli
Statistieken
Internationaal
Zwitserland | 2 |
Italië | 2 |
Operationeel
Chief Tech/Sci/R&D Officer | 2 |
Founder | 2 |
Sectoraal
Health Technology | 2 |
Commercial Services | 2 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
Bedrijven in privébezit | 2 |
---|---|
Nouscom AG
![]() Nouscom AG Pharmaceuticals: MajorHealth Technology Nouscom AG engages in the development of genetic neoantigen vaccines and oncolytic viruses for prevention and treatment of cancer. Its product pipeline include Nous-209, Nous-PEV, and Nous-THV-001. The company was founded by Alfredo Nicosia, Antonella Folgori, Riccardo Cortese, Stefano Colloca, Cinzia Traboni, Elisa Scarselli, and Gabriella Campadelli in 2007 and is headquartered in Basel, Switzerland. | Health Technology |
Nouscom Srl | Commercial Services |
- Beurs
- Insiders
- Elisa Scarselli
- Ervaring